Here you will find copies of all the ASX Announcements made by Bio-Gene (ASX:BGT) since 1 January 2023.
23-11-2023 Bio-Gene Chair Address to 2023 AGM
23-11-2023 Bio-Gene CEO Presentation to 2023 AGM
23-11-2023 Bio Gene CEO Address to 2023 AGM
13-11-2023 Resignation of Joint CFO and Company Secretary
30-10-2023 Quarterly Activities/Appendix 4C Cash Flow Report
24-10-2023 Notice of Annual General Meeting 2023
12-09-2023 Launch of SPP (Booklet Included) & Further Funds Raised in Placement
05-09-2023 Result of Placement
11-08-2023 BGT Update Company Presentation
02-08-2023 New USA patent for the pesticide market
01-08-2023 Final Director's Notice Robert Klupacs
28-07-2023 Chair appointment/resignation
28-07-2023 Quarterly Activities/Appendix 4C Cash flow report
28-07-2023 Bio-Gene appoints new CEO
27-07-2023 Bio-Gene Executes Development and License Agreement with STK
27-07-2023 Change of Director Notice - R Jagger
26-07-2023 Change of Director Notice - P May
24-07-2023 Bio-Gene Technology selected for USA CDC funded program
28-06-2023 Allowance of USA Patent
12-05-2023 Board Changes
12-05-2023 Initial Director Notice - A Ding
12-05-2023 Initial Director Notice - C Ramsey
11-05-2023 GRDC Confirms Support for Flavocide in Grain Storage
03-05-2023 Bio-Gene Company Update Presentation
27-04-2023 Appendix 4C - 31 March 2023
26-04-2023 SYNERGY STUDIES WITH FLAVOCIDETM AND QCIDETM OFFER SIGNIFICANT NEW COMMERCIAL OPPORTUNITIES FOR USE WITH OTHER INSECTICIDES
24-04-2023 RECEIPT OF NOTICES UNDER SECTIONS 203D AND 249D OF THE CORPORATIONS ACT
24-04-2023 Final Director's Interest Notice - J Joughin
24-04-2023 Final Director's Interest Notice - P Beetham
24-04-2023 Board and Management Changes
20-04-2023 Bio-Gene Business Update and March Quarterly Briefing
13-04-2023 BIO-GENE EXTENDS COMMERCIAL DEVELOPMENT AGREEMENT ON FLAVOCIDE INCREASING US MARKET OPPORTUNITY BY 150%
21-03-2023 Impending Retirement of Director - James Joughin
21-03-2023 Appointment of New Chief Financial Officer and Company Secretary
17-03-2023 Allowance of United States Patent
23-02-2023 Bio-Gene Company Update Presentation
23-02-2023 Appendix 4D - Half Year Accounts - 31 December 2022
31-01-2023 Appendix 4C - 31 December 2022
20-01-2023 Bio-Gene Receives R&D Tax Incentive
19-01-2023 BIO-GENE AND STK AGREE BINDING TERMS ON GLOBAL COLLABORATION
ASX Announcements Archive - 1 January 2022 to 31 December 2022
ASX Announcements Archive - 1 January 2021 to 31 December 2021
ASX Announcements Archive - 1 January 2020 to 31 December 2020
ASX Announcements Archive - 1 January 2019 to 31 December 2019
ASX Announcements Archive - 29 November 2017 to 31 December 2018
To be alerted about our ASX Announcements and other news on Bio-Gene you can join our mailing list here: